Lv6
2515 积分 2021-02-07 加入
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
15小时前
已完结
Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer
15小时前
已完结
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer
17小时前
已完结
Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer
1天前
已完结
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
1天前
已完结
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer
1天前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
1天前
已完结
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
1天前
已完结
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random
2天前
已完结
Immune checkpoint inhibitors combined with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
9天前
已完结
皖公网安备34019202002308
